Analysis of therapeutic potential of preclinical models based on DR3/TL1A pathway modulation

Y Yu, P Jiang, P Sun, N Su… - Experimental and …, 2021 - spandidos-publications.com
Abstract Death receptor 3 (DR3) and its corresponding ligand, tumor necrosis factor‑like
ligand 1A (TL1A), belong to the tumor necrosis factor superfamily. Signaling via this receptor …

Prognostic value of tumor mutational burden related to immune infiltration in cervical squamous cell carcinoma

F Wen, S Ruan, W Huang, X Chen, Y Wang… - Frontiers in …, 2021 - frontiersin.org
Cervical squamous cell carcinoma is one of the most common causes of female cancer
deaths worldwide. At present, immunotherapy using immune checkpoint blockade (ICB) has …

[HTML][HTML] Colonic diverticulosis. Is there a genetic component?

AM Miulescu - Maedica, 2020 - ncbi.nlm.nih.gov
Diverticular disease is a common condition among the elderly, with a steady increase in
prevalence over time. Also, it has a temporal, geographic, and ethnic variation in incidence …

The relation of VEGFA, VEGFR2, VEGI, and HIF1A genetic variants and their serum protein levels with breast cancer in Egyptian patients

AA Abdelgalil, R Monir, M Elmetwally, MH Ghattas… - Biochemical …, 2024 - Springer
Breast cancer is the most common type of cancer in Egyptian females. Polymorphisms in the
angiogenesis pathway have been implicated previously in cancer risk and prognosis. The …

Co-expression and functional interactions of death receptor 3 and E-selectin in clear cell renal cell carcinoma

RS Al-Lamki, J Wang, JS Pober, JR Bradley - The American Journal of …, 2022 - Elsevier
Similar to the behavior of inflamed tubular epithelial cells, clear cell renal cell carcinoma
(ccRCC) cells express death receptor 3 (DR3 or TNFSFR25) in situ, and expression …

Targeting TNFRSF25 by agonistic antibodies and multimeric TL1A proteins co-stimulated CD8+ T cells and inhibited tumor growth

X Lyu, L Zhao, S Chen, Y Li, Y Yang, H Liu… - … for ImmunoTherapy of …, 2024 - jitc.bmj.com
Background Tumor necrosis factor receptor superfamily 25 (TNFRSF25) is a T-cell co-
stimulatory receptor. Expression of its ligand, TNF-like cytokine 1A (TL1A), on mouse tumor …

TNFSF15对肿瘤脉管生成调控的临床意义及研究进展

秦婷婷, 李凯 - 肿瘤防治研究, 2020 - zlfzyj.com
肿瘤坏死因子超家族成员15 (TNFSF15) 主要是由血管内皮细胞特异分泌的细胞因子.
作为死亡受体3 (DR3) 的配体, 它参与调控VEGF/VEGFR 信号通路, 进而影响多种脉管细胞的 …

[HTML][HTML] Hypomethylation of Tumor necrosis factor-like cytokine 1A (TL1A) and its decoy receptor 3 expressive level increase has diagnostic value in HBV-associated …

XF Wei, JY Zhu, HH Liu, X Su, JH Li, YC Fan, K Wang - Virology, 2023 - Elsevier
For patients with cirrhosis, early diagnosis is the key to delaying the development of liver
fibrosis and improving prognosis. This study aimed to investigate the clinical significance of …

Role of TNFSF15 variants in oral cancer development and clinicopathologic characteristics

HJ Lu, CY Chuang, CW Su, MK Chen… - Journal of Cellular …, 2022 - Wiley Online Library
Tumour necrosis family superfamily (TNFSF) member 15 (TNFSF15), encoded by TNFSF15,
regulates immune responses and inflammation. However, the roles of TNFSF15 single …

Genomic Approaches for Drug Repurposing

K Dave, M Sharma, D Patel, PS Dhanda, A Yadav… - 2024 - preprints.org
Functional genomics, a multidisciplinary subject, investigates the functions of genes and
their products in biological systems to better understand diseases and find new drugs. Drug …